InMedica Development Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for InMedica Development Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

InMedica Development Corporation. The Group's principal activities is to develop and sale of medical technology. It develops and markets portable electrocardiograph (ECG) monitor. Other activity is to research and develop a device to measure hematocrit technology. The hematocrit is the percentage of red blood cells in a given volume of blood. It entered into a Development, Licensing and Manufacturing agreement with Chi Lin pursuant to which InMedica granted Chi Lin a worldwide license to develop and manufacture products based on the hematocrit technology. The Group operates throughout the United States. On 12-Dec-2008, the Group acquired ValuMobile, LLC.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report